ID   PAK2_RAT                Reviewed;         524 AA.
AC   Q64303; Q9QYU0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 196.
DE   RecName: Full=Serine/threonine-protein kinase PAK 2;
DE            EC=2.7.11.1;
DE   AltName: Full=Gamma-PAK;
DE   AltName: Full=p21-activated kinase 2;
DE            Short=PAK-2;
DE   Contains:
DE     RecName: Full=PAK-2p27;
DE   Contains:
DE     RecName: Full=PAK-2p34;
GN   Name=Pak2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Brain, and Testis;
RX   PubMed=7592896; DOI=10.1074/jbc.270.44.26690;
RA   Teo M., Manser E., Lim L.;
RT   "Identification and molecular cloning of a p21cdc42/rac1-activated
RT   serine/threonine kinase that is rapidly activated by thrombin in
RT   platelets.";
RL   J. Biol. Chem. 270:26690-26697(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Mabel T.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Forebrain;
RA   Marcus S., Polverino A., Robbins D., Hutchison M., Xu H., Asouline G.,
RA   Cobb M., Wigler M.;
RT   "Conservation of STE20-responsive MAP kinase activation in eukaryotic
RT   organisms.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-59; SER-141; THR-143
RP   AND SER-152, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine protein kinase that plays a role in a
CC       variety of different signaling pathways including cytoskeleton
CC       regulation, cell motility, cell cycle progression, apoptosis or
CC       proliferation. Acts as a downstream effector of the small GTPases CDC42
CC       and RAC1. Activation by the binding of active CDC42 and RAC1 results in
CC       a conformational change and a subsequent autophosphorylation on several
CC       serine and/or threonine residues. Full-length PAK2 stimulates cell
CC       survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates
CC       the downstream target MAPKAPK5, a regulator of F-actin polymerization
CC       and cell migration. Phosphorylates JUN and plays an important role in
CC       EGF-induced cell proliferation. Phosphorylates many other substrates
CC       including histone H4 to promote assembly of H3.3 and H4 into
CC       nucleosomes, BAD, ribosomal protein S6, or MBP. Phosphorylates CASP7,
CC       thereby preventing its activity. Additionally, associates with ARHGEF7
CC       and GIT1 to perform kinase-independent functions such as spindle
CC       orientation control during mitosis. On the other hand, apoptotic
CC       stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2,
CC       generating PAK-2p34, an active p34 fragment that translocates to the
CC       nucleus and promotes cellular apoptosis involving the JNK signaling
CC       pathway. Caspase-activated PAK2 phosphorylates MKNK1 and reduces
CC       cellular translation (By similarity). {ECO:0000250|UniProtKB:Q13177}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q13177};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000250|UniProtKB:Q13177};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q13177};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000250|UniProtKB:Q13177};
CC   -!- ACTIVITY REGULATION: Activated by binding small G proteins. Binding of
CC       GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers
CC       from the autoinhibited dimer, enables phosphorylation of Thr-402 and
CC       allows the kinase domain to adopt an active structure. Following
CC       caspase cleavage, autophosphorylated PAK-2p34 is constitutively active
CC       (By similarity). {ECO:0000250|UniProtKB:Q13177}.
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound CDC42/p21
CC       and RAC1. Interacts with SH3MD4. Interacts with SCRIB. Interacts with
CC       ARHGEF7 and GIT1. PAK-2p34 interacts with ARHGAP10. Interacts with RAC1
CC       (By similarity). {ECO:0000250|UniProtKB:Q13177}.
CC   -!- SUBCELLULAR LOCATION: [Serine/threonine-protein kinase PAK 2]:
CC       Cytoplasm {ECO:0000250|UniProtKB:Q13177}. Nucleus
CC       {ECO:0000250|UniProtKB:Q13177}. Note=MYO18A mediates the cellular
CC       distribution of the PAK2-ARHGEF7-GIT1 complex to the inner surface of
CC       the cell membrane. {ECO:0000250|UniProtKB:Q13177}.
CC   -!- SUBCELLULAR LOCATION: [PAK-2p34]: Nucleus
CC       {ECO:0000250|UniProtKB:Q13177}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q13177}. Membrane
CC       {ECO:0000250|UniProtKB:Q13177}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q13177}. Note=Interaction with ARHGAP10 probably
CC       changes PAK-2p34 location to cytoplasmic perinuclear region.
CC       Myristoylation changes PAK-2p34 location to the membrane.
CC       {ECO:0000250|UniProtKB:Q13177}.
CC   -!- PTM: Full-length PAK2 is autophosphorylated when activated by
CC       CDC42/p21. Following cleavage, both peptides, PAK-2p27 and PAK-2p34,
CC       become highly autophosphorylated. Autophosphorylation of PAK-2p27 can
CC       occur in the absence of any effectors and is dependent on
CC       phosphorylation of Thr-402, because PAK-2p27 is acting as an exogenous
CC       substrate (By similarity). {ECO:0000250|UniProtKB:Q13177}.
CC   -!- PTM: During apoptosis proteolytically cleaved by caspase-3 or caspase-
CC       3-like proteases to yield active PAK-2p34.
CC       {ECO:0000250|UniProtKB:Q13177}.
CC   -!- PTM: Ubiquitinated, leading to its proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q13177}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S80221; AAB35608.1; -; mRNA.
DR   EMBL; U35345; AAA79064.1; -; mRNA.
DR   EMBL; U19967; AAF06695.1; -; mRNA.
DR   RefSeq; NP_445758.2; NM_053306.3.
DR   RefSeq; XP_003751114.1; XM_003751066.3.
DR   RefSeq; XP_006248535.1; XM_006248473.2.
DR   RefSeq; XP_008767000.1; XM_008768778.2.
DR   PDB; 2DF6; X-ray; 1.30 A; C/D=180-197.
DR   PDBsum; 2DF6; -.
DR   AlphaFoldDB; Q64303; -.
DR   SMR; Q64303; -.
DR   BioGRID; 248079; 5.
DR   IntAct; Q64303; 1.
DR   STRING; 10116.ENSRNOP00000065949; -.
DR   iPTMnet; Q64303; -.
DR   PhosphoSitePlus; Q64303; -.
DR   jPOST; Q64303; -.
DR   PaxDb; 10116-ENSRNOP00000040162; -.
DR   Ensembl; ENSRNOT00000049862.4; ENSRNOP00000040162.2; ENSRNOG00000001747.6.
DR   Ensembl; ENSRNOT00060043834; ENSRNOP00060036373; ENSRNOG00060025077.
DR   Ensembl; ENSRNOT00065034281; ENSRNOP00065027452; ENSRNOG00065020237.
DR   GeneID; 29432; -.
DR   KEGG; rno:29432; -.
DR   UCSC; RGD:61953; rat.
DR   AGR; RGD:61953; -.
DR   CTD; 5062; -.
DR   RGD; 61953; Pak2.
DR   eggNOG; KOG0578; Eukaryota.
DR   GeneTree; ENSGT00950000182988; -.
DR   HOGENOM; CLU_000288_26_6_1; -.
DR   InParanoid; Q64303; -.
DR   OMA; MDFPPLR; -.
DR   OrthoDB; 460351at2759; -.
DR   PhylomeDB; Q64303; -.
DR   TreeFam; TF105351; -.
DR   BRENDA; 2.7.12.2; 5301.
DR   Reactome; R-RNO-202433; Generation of second messenger molecules.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-RNO-3928664; Ephrin signaling.
DR   Reactome; R-RNO-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-445355; Smooth Muscle Contraction.
DR   Reactome; R-RNO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-RNO-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-RNO-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013404; RAC2 GTPase cycle.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   Reactome; R-RNO-9013407; RHOH GTPase cycle.
DR   Reactome; R-RNO-9013408; RHOG GTPase cycle.
DR   Reactome; R-RNO-9013420; RHOU GTPase cycle.
DR   Reactome; R-RNO-9013424; RHOV GTPase cycle.
DR   EvolutionaryTrace; Q64303; -.
DR   PRO; PR:Q64303; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001747; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0034333; P:adherens junction assembly; ISO:RGD.
DR   GO; GO:0070830; P:bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0060996; P:dendritic spine development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0051497; P:negative regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:0016310; P:phosphorylation; IEA:Ensembl.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0150105; P:protein localization to cell-cell junction; ISO:RGD.
DR   GO; GO:0050770; P:regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   CDD; cd01093; CRIB_PAK_like; 1.
DR   CDD; cd06655; STKc_PAK2; 1.
DR   Gene3D; 3.90.810.10; CRIB domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR036936; CRIB_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR033923; PAK_BD.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050285; STE20_Ser/Thr_kinase.
DR   InterPro; IPR035064; STK_PAK2.
DR   PANTHER; PTHR48015; SERINE/THREONINE-PROTEIN KINASE TAO; 1.
DR   PANTHER; PTHR48015:SF22; SERINE_THREONINE-PROTEIN KINASE PAK 2; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Kinase; Lipoprotein; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   CHAIN           2..524
FT                   /note="Serine/threonine-protein kinase PAK 2"
FT                   /id="PRO_0000086468"
FT   CHAIN           2..212
FT                   /note="PAK-2p27"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT                   /id="PRO_0000304928"
FT   CHAIN           213..524
FT                   /note="PAK-2p34"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT                   /id="PRO_0000304929"
FT   DOMAIN          74..87
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   DOMAIN          249..500
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..81
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          69..137
FT                   /note="Autoregulatory region"
FT                   /evidence="ECO:0000250|UniProtKB:Q13153"
FT   REGION          69..112
FT                   /note="GTPase-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13153"
FT   REGION          88..248
FT                   /note="Linker"
FT   REGION          142..190
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          204..228
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           245..251
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   COMPBIAS        61..78
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        368
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         255..263
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         278
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            212..213
FT                   /note="Cleavage; by caspase-3 or caspase-3-like proteases"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         59
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         60
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CIN4"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         128
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         134
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         139
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         143
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         154
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         159
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CIN4"
FT   MOD_RES         169
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   MOD_RES         402
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13177"
FT   CONFLICT        82
FT                   /note="H -> Y (in Ref. 3; AAF06695)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="K -> E (in Ref. 3; AAF06695)"
FT                   /evidence="ECO:0000305"
FT   HELIX           188..190
FT                   /evidence="ECO:0007829|PDB:2DF6"
SQ   SEQUENCE   524 AA;  57960 MW;  A3F2FEE81C8D4294 CRC64;
     MSDNGELEDK PPAPPVRMSS TIFSTGGKDP LSANHSLKPL PSVPEEKKPR NKIISIFSST
     EKGSKKKEKE RPEISPPSDF EHTIHVGFDA VTGEFTGMPE QWARLLQTSN ITKLEQKKNP
     QAVLDVLKFY DSNTVKQKYL SFTPPEKDGF PSGTPALNTK GSETSAVVTE EDDDDEDAAP
     PVIAPRPDHT KSIYTRSVID PIPAPVGDSN VDSGAKSSDK QKKKAKMTDE EIMEKLRTIV
     SIGDPKKKYT RYEKIGQGAS GTVFTATDVA LGQEVAIKQI NLQKQPKKEL IINEILVMKE
     LKNPNIVNFL DSYLVGDELF VVMEYLAGGS LTDVVTETCM DEAQIAAVCR ECLQALEFLH
     ANQVIHRDIK SDNVLLGMEG SVKLTDFGFC AQITPEQSKR STMVGTPYWM APEVVTRKAY
     GPKVDIWSLG IMAIEMVEGE PPYLNENPLR ALYLIATNGT PELQNPEKLS PIFRDFLNRC
     LEMDVEKRGS AKELLQHPFL KLAKPLSSLT PLILAAKEAM KSNR
//
